Liver injury due to herbal and dietary supplements: A review of individual ingredients
Elizabeth Zheng, Victor Navarro – 27 April 2016
Abnormal liver tests after liver transplantation
Andrew Fedoravicius, Michael Charlton – 27 April 2016
Combined liver–dual kidney transplant: Role in expanded donors
Marco Di Laudo, Matteo Ravaioli, Gaetano La Manna, Giorgia Comai, Matteo Cescon, Massimo Del Gaudio, Chiara Zanfi, Alessandro Cucchetti, Giorgio Ercolani, Antonio Daniele Pinna – 26 April 2016 – Kidney injury is a common clinical feature among liver transplantation (LT) candidates that heavily affects prognosis and complicates the surgical decision‐making process. Up to 20% of patients undergoing LT demonstrate some degree of renal impairment, and 2% will benefit from a combined liver‐kidney transplantation (LKT).
Clinical outcomes after coronary angiography in nonalcoholic fatty liver disease
Savas Sarikaya, Yasar Turan, Mehmet Celikbilek – 26 April 2016
Cholangiocarcinoma risk factors and the potential role of aspirin
Fabio Bagante, T. Clark Gamblin, Timothy M. Pawlik – 26 April 2016
Editorial Board
26 April 2016
Reply
Natasha K. Martin, Peter Vickerman, Matthew Hickman – 26 April 2016
Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management
Delphine Nicolle, Monique Fabre, Marina Simon‐Coma, Aurore Gorse, Roland Kappler, Lara Nonell, Mar Mallo, Hazar Haidar, Olivier Déas, Charlotte Mussini, Catherine Guettier, Marie‐José Redon, Laurence Brugières, Maria Rosa Ghigna, Elie Fadel, Louise Galmiche‐Rolland, Christophe Chardot, Jean‐Gabriel Judde, Carolina Armengol, Sophie Branchereau, Stefano Cairo – 26 April 2016 – Identification of new treatments for relapsing pediatric cancer is an unmet clinical need and a societal challenge.
Reply
Veronica Miller, Patrick Harrington, Anita Howe, Tara Kieffer, Johan Lennerstrand, Oliver Lenz, Erik Lontok, Fiona McPhee, Hongmei Mo, Neil Parkin, Tami Pilot‐Matias – 26 April 2016